Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dan Peer

Showing results (1-10 of 181) with videos related to

Pageof 19
Sort By:
Molecular and Cellular Therapies|June 10, 2015
Harnessing RNAi nanomedicine for precision therapyDan Peer
Advanced Drug Delivery Reviews|July 24, 2012
Immunotoxicity derived from manipulating leukocytes with lipid-based nanoparticlesDan Peer
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 14, 2010
Induction of therapeutic gene silencing in leukocyte-implicated diseases by targeted and stabilized nanoparticles: a mini-reviewDan Peer
Immunological Reviews|April 5, 2013
A daunting task: manipulating leukocyte function with RNAiDan Peer
Cancer Letters|April 1, 2014
Featuring the special issue guest editor: Dan Peer, Ph.DDan Peer
Cancer Letters|April 29, 2014
Precision medicine--delivering the goods?Dan Peer
Nanomedicine (London, England)|May 18, 2023
Drug-delivery research and much more: interview with Dan PeerDan Peer
Theranostics|January 7, 2020
Monoclonal antibody-based molecular imaging strategies and theranostic opportunitiesNiels Dammes, Dan Peer
Bioactive Materials|October 3, 2022
Genome editing in cancer: Challenges and potential opportunitiesDor Breier, Dan Peer
International Journal of Cancer|December 30, 2003
Loading mitomycin C inside long circulating hyaluronan targeted nano-liposomes increases its antitumor activity in three mice tumor modelsDan Peer, Rimona Margalit
Pageof 19

Showing results (1-10 of 181) with videos related to

Sort By:
Pageof 19
Molecular and Cellular Therapies|June 10, 2015
Harnessing RNAi nanomedicine for precision therapyDan Peer
Advanced Drug Delivery Reviews|July 24, 2012
Immunotoxicity derived from manipulating leukocytes with lipid-based nanoparticlesDan Peer
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 14, 2010
Induction of therapeutic gene silencing in leukocyte-implicated diseases by targeted and stabilized nanoparticles: a mini-reviewDan Peer
Immunological Reviews|April 5, 2013
A daunting task: manipulating leukocyte function with RNAiDan Peer
Cancer Letters|April 1, 2014
Featuring the special issue guest editor: Dan Peer, Ph.DDan Peer
Cancer Letters|April 29, 2014
Precision medicine--delivering the goods?Dan Peer
Nanomedicine (London, England)|May 18, 2023
Drug-delivery research and much more: interview with Dan PeerDan Peer
Theranostics|January 7, 2020
Monoclonal antibody-based molecular imaging strategies and theranostic opportunitiesNiels Dammes, Dan Peer
Bioactive Materials|October 3, 2022
Genome editing in cancer: Challenges and potential opportunitiesDor Breier, Dan Peer
International Journal of Cancer|December 30, 2003
Loading mitomycin C inside long circulating hyaluronan targeted nano-liposomes increases its antitumor activity in three mice tumor modelsDan Peer, Rimona Margalit
Pageof 19